Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Journal of Gastroenterology and Hepatology
|
March 19, 2020
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan
Takashi Kitagataya, Goki Suda, Kazunori Nagashima, et al.
Cancers
|
August 26, 2022
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
Takuya Sho, Goki Suda, Yoshiya Yamamoto, et al.
Seminars in Oncology
|
June 10, 2025
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population
Francesco Vitiello, Toshifumi Tada, Goki Suda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Global Health & Medicine
|
September 19, 2022
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
Masaaki Korenaga, Kazumoto Murata, Namiki Izumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, et al.
Journal of Gastroenterology
|
July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
Goki Suda, Masayuki Kurosaki, Jun Itakura, et al.
JHEP Reports : Innovation in Hepatology
|
August 18, 2025
Restoration of the gut-microbiota-liver axis after hepatitis C virus eradication
Takako Inoue, Jiro Nakayama, Hiroshi Mori, et al.
Liver Cancer
|
January 2, 2023
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study
Andrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, et al.
Journal of Medical Virology
|
January 4, 2023
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis
Goki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Journal of Gastroenterology and Hepatology
|
March 19, 2020
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan
Takashi Kitagataya, Goki Suda, Kazunori Nagashima, et al.
Cancers
|
August 26, 2022
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
Takuya Sho, Goki Suda, Yoshiya Yamamoto, et al.
Seminars in Oncology
|
June 10, 2025
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population
Francesco Vitiello, Toshifumi Tada, Goki Suda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Global Health & Medicine
|
September 19, 2022
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
Masaaki Korenaga, Kazumoto Murata, Namiki Izumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study
Federica Lo Prinzi, Federico Rossari, Antonio De Rosa, et al.
Journal of Gastroenterology
|
July 19, 2018
Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
Goki Suda, Masayuki Kurosaki, Jun Itakura, et al.
JHEP Reports : Innovation in Hepatology
|
August 18, 2025
Restoration of the gut-microbiota-liver axis after hepatitis C virus eradication
Takako Inoue, Jiro Nakayama, Hiroshi Mori, et al.
Liver Cancer
|
January 2, 2023
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study
Andrea Casadei-Gardini, Margherita Rimini, Masatoshi Kudo, et al.
Journal of Medical Virology
|
January 4, 2023
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis
Goki Suda, Masaru Baba, Yoshiya Yamamoto, et al.
Page
of 15